Shape Therapeutics nets $35.5 mln Series A

Seattle-based Shape Therapeutics Inc, a developer of a RNA and protein targeting platform focused on curing human diseases, has secured $35.5 million in Series A financing. New Enterprise Associates led the round participation from CureDuchenne Ventures.

Source: Press Release